# sCD163 as a Potential Biomarker in Guillain- Barré Syndrome

> **NCT02582853** · — · UNKNOWN · sponsor: **University of Aarhus** · enrollment: 60 (estimated)

## Conditions studied

- Guillain-Barre Syndrome

## Interventions

- **PROCEDURE:** Lumbar puncture
- **PROCEDURE:** Blood Sample

## Key facts

- **NCT ID:** NCT02582853
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2016-11
- **Final completion:** 2018-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582853, "sCD163 as a Potential Biomarker in Guillain- Barré Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02582853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*